A Prospective, Multicentre, Non-interventional, Observational, Post-authorisation Safety Study of Ropeginterferon alfa-2b in Polycythaemia Vera Patients (Besremi-PASS)

First published 24/04/2019

Last updated 21/02/2025

EU PAS number:

EUPAS29462

Study

Ongoing

Documents

Study protocol

Initial protocol

190913_Ropeg PASS_Protocol_2.0_Redacted

English (328.29 KB - PDF)View document

Updated protocol

Ropeg PASS_Protocol_2.3_26Apr2022_clean_Redacted

First published: 22/02/2024

English (348.94 KB - PDF)View document

Study results

Study report

Other information

Study, other information

Besremi-PASS_Protocol Redacted_V2.2_16Jun2020

English (335.13 KB - PDF)View document

ENCePP Seal

ENCePP Seal documents

Secondary tabs